SC 13D/AAMENDMENTTBPHCIK 0001583107

Theravance Biopharma, Inc.

Name: SEC EDGAR filing 0001193125-26-402801
Creator: Theravance Biopharma, Inc.
License: https://www.usa.gov/government-works

5%+ activist stake (SC 13D/A) filed September 25, 2026.

Disclosure of beneficial ownership above 5% with intent to influence company control.

Open the filing on SEC.gov

New to the SC 13D/A? What it is and how to read one

Filing facts

Accession number: 0001193125-26-402801
Filer: Theravance Biopharma, Inc.
Ticker: TBPH
CIK: 0001583107
Form type: SC 13D/A
Form description: 5%+ activist stake
Filed at: September 25, 2026
Industry: SIC 2834Pharmaceutical Preparations
Last verified: September 25, 2026SecFilingDex pulls from EDGAR with daily cadence

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1583107/000119312526402801/0001193125-26-402801-index.htm ↗

Filer's full EDGAR submission history

EDGAR · Theravance Biopharma, Inc. (0001583107) ↗

Machine-readable JSON twin (LLM-citation friendly)

/api/filing/0001193125-26-402801.json

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.